Fort Washington Investment Advisors 13F: Exits CERT Stake

Fort Washington Investment Advisors has sold out of its position in Certara, Inc. (NasdaqGS: CERT), completely exiting with a reduction of 2,864,204 shares as of its filing on October 15, 2026. This move leaves the firm with no remaining shares after previously holding the position valued at approximately $26.5 million.

What Changed in Fort Washington Investment Advisors' Certara Position

This filing shows that Fort Washington Investment Advisors cut its position by 100%, from 2,864,204 shares down to zero. The firm has sold all of its stake in Certara, reflecting a strategic shift.

Other Institutional Activity in Certara

BlackRock Inc. grew its holdings by 4,509,953 shares, ending with 18,818,180 shares worth about $176.3 million. Haveli Investment Management LLC increased its stake by 3,700,000 shares, bringing its total to 7,400,000 shares valued at approximately $69.3 million. Vanguard Portfolio Management LLC added 1,086,978 shares, resulting in a total of 7,056,106 shares worth around $66.1 million. Meanwhile, Deerfield Management Company, L.P. reduced its holdings by 295,957 shares, now holding 7,512,928 shares valued at about $70.4 million.

Certara, Inc. Stock Down 4.2%

As of October 16, 2026, Certara shares recently traded around $9.26, which is above its 50-day moving average by about 8.7% and its 200-day moving average by about 28.6%. However, the shares are still below their 52-week high of $12.94, showing a decline of about 28.4%. The stock has also performed well above its 52-week low of $4.45, gaining over 108% since that point.

Recent Earnings

Certara reported trailing twelve-month revenue of $421.7 million, marking a year-over-year growth of 1.0%. However, the company has not turned a profit, as indicated by a negative net margin of -16.2% and an earnings per share (EPS) of -$0.14. The next earnings date is set for November 5, 2026.

Insider Buying and Selling at Certara, Inc.

On September 9, 2025, Leif E. Pedersen, the President, sold 51,224 shares at an average price of $10.92, totaling about $559,366. Meanwhile, on November 11, 2025, CEO William F. Feehery bought 24,096 shares at an average price of $8.30, amounting to around $200,000.

Analysts Set New Price Targets

On October 16, 2026, KeyBanc maintained an 'Overweight' rating for Certara with a price target of $12.00. Earlier, TD Cowen also maintained its 'Buy' rating with a target of $11.00 on October 13, 2026. Currently, the analysts have a consensus recommendation of 'buy' with a mean price target of $9.17.

About Certara, Inc.

Certara, Inc. provides technology-driven services and software products aimed at biosimulation in drug discovery and clinical research among other services. The company operates across the Americas, Europe, the Middle East, Africa, and Asia Pacific. This recent sell-off by Fort Washington may indicate a reevaluation of their investment strategy in this sector.

Bottom Line

Investors should note that Fort Washington's filing reflects its holdings as of the reporting period, and may not represent its current position. With the next earnings date approaching on November 5, 2026, it will be important to monitor any further developments in Certara's performance and analyst updates.